1	Solid	Solid	B-NP	JJ	O	3	NMOD	0
2	tumor	tumor	I-NP	NN	O	3	NMOD	0
3	therapy	therapy	I-NP	NN	O	5	NMOD	19	therapy
4	:	:	O	:	O	3	P	0
5	manipulation	manipulation	B-NP	NN	O	0	ROOT	16	manipulation
6	of	of	B-PP	IN	O	5	NMOD	0
7	the	the	B-NP	DT	O	8	NMOD	0
8	vasculature	vasculature	I-NP	NN	O	6	PMOD	0
9	with	with	B-PP	IN	O	8	NMOD	0
10	TNF	TNF	B-NP	NN	B-protein	9	PMOD	0
11	.	.	O	.	O	5	P	0

1	Drug	Drug	B-NP	NN	O	2	NMOD	0
2	delivery	delivery	I-NP	NN	O	6	SUB	0
3	to	to	B-PP	TO	O	2	NMOD	0
4	solid	solid	B-NP	JJ	O	5	NMOD	0
5	tumors	tumor	I-NP	NNS	O	3	PMOD	0
6	is	be	B-VP	VBZ	O	0	ROOT	0
7	one	one	B-NP	CD	O	6	PRD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	12	NMOD	0
10	most	most	I-NP	RBS	O	11	AMOD	0
11	challenging	challenging	I-NP	JJ	O	12	NMOD	0
12	aspects	aspect	I-NP	NNS	O	8	PMOD	0
13	in	in	B-PP	IN	O	12	NMOD	0
14	cancer	cancer	B-NP	NN	O	15	NMOD	0
15	therapy	therapy	I-NP	NN	O	13	PMOD	0
16	.	.	O	.	O	6	P	0

1	Whereas	Whereas	B-SBAR	IN	O	13	VMOD	0
2	agents	agent	B-NP	NNS	O	3	SUB	0
3	seem	seem	B-VP	VBP	O	1	SBAR	0
4	promising	promising	B-ADJP	JJ	O	3	PRD	0
5	in	in	B-PP	IN	O	4	AMOD	0
6	the	the	B-NP	DT	O	8	NMOD	0
7	test	test	I-NP	NN	O	8	NMOD	0
8	tube	tube	I-NP	NN	O	5	PMOD	0
9	,	,	O	,	O	13	P	0
10	clinical	clinical	B-NP	JJ	O	11	NMOD	0
11	trials	trial	I-NP	NNS	O	13	SUB	0
12	often	often	B-ADVP	RB	O	13	VMOD	0
13	fail	fail	B-VP	VBP	O	0	ROOT	0
14	due	due	B-PP	JJ	O	28	NMOD	0
15	to	to	B-PP	TO	O	14	AMOD	0
16	unfavorable	unfavorable	B-NP	JJ	O	17	NMOD	0
17	pharmacokinetics	pharmacokinetic	I-NP	NNS	O	15	PMOD	0
18	,	,	O	,	O	28	P	0
19	poor	poor	B-NP	JJ	O	20	NMOD	0
20	delivery	delivery	I-NP	NN	O	28	NMOD	0
21	,	,	O	,	O	28	P	0
22	low	low	B-NP	JJ	O	24	NMOD	0
23	local	local	I-NP	JJ	O	24	NMOD	0
24	concentrations	concentration	I-NP	NNS	O	28	NMOD	0
25	,	,	O	,	O	28	P	0
26	and	and	O	CC	O	28	NMOD	0
27	limited	limited	B-NP	JJ	O	28	NMOD	0
28	accumulation	accumulation	I-NP	NN	O	13	OBJ	0
29	in	in	B-PP	IN	O	28	NMOD	0
30	the	the	B-NP	DT	O	32	NMOD	0
31	target	target	I-NP	NN	B-cell_type	32	NMOD	0
32	cell	cell	I-NP	NN	I-cell_type	29	PMOD	0
33	.	.	O	.	O	13	P	0

1	A	A	B-NP	DT	O	4	NMOD	0
2	major	major	I-NP	JJ	O	4	NMOD	0
3	step	step	I-NP	NN	O	4	NMOD	0
4	forwards	forward	I-NP	NNS	O	11	SUB	0
5	in	in	B-PP	IN	O	4	NMOD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	treatment	treatment	I-NP	NN	O	5	PMOD	19	treatment
8	of	of	B-PP	IN	O	7	NMOD	0
9	solid	solid	B-NP	JJ	O	10	NMOD	0
10	tumors	tumor	I-NP	NNS	O	8	PMOD	0
11	is	be	B-VP	VBZ	O	0	ROOT	0
12	the	the	B-NP	DT	O	13	NMOD	0
13	recognition	recognition	I-NP	NN	O	11	PRD	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	the	the	B-NP	DT	O	17	NMOD	0
16	tumor-associated	tumor-associated	I-NP	JJ	O	17	NMOD	0
17	vasculature	vasculature	I-NP	NN	O	14	PMOD	0
18	as	as	B-PP	IN	O	13	NMOD	0
19	an	an	B-NP	DT	O	21	NMOD	0
20	important	important	I-NP	JJ	O	21	NMOD	0
21	target	target	I-NP	NN	O	18	PMOD	0
22	for	for	B-PP	IN	O	21	NMOD	0
23	therapy	therapy	B-NP	NN	O	22	PMOD	0
24	.	.	O	.	O	11	P	0

1	Inhibition	Inhibition	B-NP	NN	O	6	SUB	18	Inhibition
2	of	of	B-PP	IN	O	1	NMOD	0
3	tumor	tumor	B-NP	NN	O	5	NMOD	0
4	vascular	vascular	I-NP	JJ	O	5	NMOD	0
5	development	development	I-NP	NN	O	2	PMOD	2	development
6	has	have	B-VP	VBZ	O	0	ROOT	0
7	a	a	B-NP	DT	O	9	NMOD	0
8	direct	direct	I-NP	JJ	O	9	NMOD	0
9	effect	effect	I-NP	NN	O	6	OBJ	16	effect
10	on	on	B-PP	IN	O	6	VMOD	0
11	the	the	B-NP	DT	O	14	NMOD	0
12	growth	growth	I-NP	NN	O	14	NMOD	4	growth
13	and	and	I-NP	CC	O	14	NMOD	0
14	progression	progression	I-NP	NN	O	10	PMOD	2	progression
15	of	of	B-PP	IN	O	14	NMOD	0
16	the	the	B-NP	DT	O	17	NMOD	0
17	tumor	tumor	I-NP	NN	O	15	PMOD	0
18	.	.	O	.	O	6	P	0

1	Destruction	Destruction	B-NP	NN	O	8	SUB	6	Destruction
2	of	of	B-PP	IN	O	1	NMOD	0
3	an	an	B-NP	DT	O	5	NMOD	0
4	existing	exist	I-NP	VBG	O	5	NMOD	0
5	vasculature	vasculature	I-NP	NN	O	2	PMOD	0
6	also	also	B-ADVP	RB	O	8	VMOD	0
7	directly	directly	B-VP	RB	O	8	VMOD	0
8	inflicts	inflict	I-VP	VBZ	O	0	ROOT	17	inflicts
9	serious	serious	B-NP	JJ	O	10	NMOD	0
10	damage	damage	I-NP	NN	O	8	OBJ	6	damage
11	to	to	B-PP	TO	O	8	VMOD	0
12	the	the	B-NP	DT	O	14	NMOD	0
13	tumor	tumor	I-NP	NN	B-cell_type	14	NMOD	0
14	cell	cell	I-NP	NN	I-cell_type	11	PMOD	0
15	.	.	O	.	O	8	P	0

1	Moreover	Moreover	B-ADVP	RB	O	7	VMOD	0
2	,	,	O	,	O	7	P	0
3	the	the	B-NP	DT	O	6	NMOD	0
4	tumor	tumor	I-NP	NN	O	6	NMOD	0
5	vascular	vascular	I-NP	JJ	O	6	NMOD	0
6	bed	bed	I-NP	NN	O	7	SUB	0
7	can	can	B-VP	MD	O	0	ROOT	0
8	be	be	I-VP	VB	O	7	VC	0
9	manipulated	manipulate	I-VP	VBN	O	8	VC	16	manipulated
10	facilitating	facilitate	B-VP	VBG	O	9	VMOD	0
11	enhanced	enhance	B-NP	VBN	O	12	NMOD	0
12	permissiveness	permissiveness	I-NP	NN	O	10	OBJ	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	tumor	tumor	I-NP	NN	O	13	PMOD	0
16	for	for	B-PP	IN	O	12	NMOD	0
17	administered	administer	B-NP	VBN	O	18	NMOD	19	administered
18	chemotherapeutics	chemotherapeutic	I-NP	NNS	O	16	PMOD	0
19	.	.	O	.	O	7	P	0

1	In	In	B-PP	IN	O	6	VMOD	0
2	this	this	B-NP	DT	O	3	NMOD	0
3	review	review	I-NP	NN	O	1	PMOD	0
4	,	,	O	,	O	6	P	0
5	we	we	B-NP	PRP	O	6	SUB	0
6	focus	focus	B-VP	VBP	O	0	ROOT	0
7	on	on	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	use	use	I-NP	NN	O	7	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	tumor	tumor	B-NP	NN	B-protein	14	NMOD	0
12	necrosis	necrosis	I-NP	NN	I-protein	14	NMOD	0
13	factor	factor	I-NP	NN	I-protein	14	NMOD	0
14	alpha	alpha	I-NP	NN	I-protein	10	PMOD	0
15	(	(	O	(	O	17	DEP	0
16	TNF	TNF	B-NP	NN	B-protein	17	DEP	0
17	)	)	O	)	O	14	NMOD	0
18	in	in	B-PP	IN	O	9	NMOD	0
19	local	local	B-NP	JJ	O	21	AMOD	0
20	and	and	I-NP	CC	O	21	AMOD	0
21	systemic	systemic	I-NP	JJ	O	22	NMOD	0
22	therapy	therapy	I-NP	NN	O	18	PMOD	19	therapy
23	in	in	B-PP	IN	O	9	NMOD	0
24	conjunction	conjunction	B-NP	NN	O	23	PMOD	0
25	with	with	B-PP	IN	O	24	NMOD	0
26	chemotherapy	chemotherapy	B-NP	NN	O	25	PMOD	0
27	.	.	O	.	O	6	P	0

1	In	In	B-PP	IN	O	5	VMOD	0
2	these	these	B-NP	DT	O	4	NMOD	0
3	settings	setting	I-NP	NNS	O	4	NMOD	0
4	TNF	TNF	I-NP	NN	B-protein	5	SUB	0
5	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT	0
6	potent	potent	B-NP	JJ	O	8	AMOD	0
7	and	and	I-NP	CC	O	8	AMOD	0
8	selective	selective	I-NP	JJ	O	9	NMOD	0
9	activity	activity	I-NP	NN	O	5	OBJ	0
10	on	on	B-PP	IN	O	9	NMOD	0
11	the	the	B-NP	DT	O	14	NMOD	0
12	tumor	tumor	I-NP	NN	O	14	NMOD	0
13	vascular	vascular	I-NP	JJ	O	14	NMOD	0
14	bed	bed	I-NP	NN	O	10	PMOD	0
15	,	,	O	,	O	14	P	0
16	which	which	B-NP	WDT	O	14	NMOD	0
17	strongly	strongly	B-VP	RB	O	18	VMOD	0
18	improves	improve	I-VP	VBZ	O	16	SBAR	17	improves
19	tumor	tumor	B-NP	NN	O	20	NMOD	0
20	response	response	I-NP	NN	O	18	OBJ	0
21	.	.	O	.	O	5	P	0

